In this episode, Anousha is joined by Dr. Su Wang, Medical Director of the Chinese Medical Program at Cooperman Barnabas Medical Center and Medical Advisor to the Hepatitis B Foundation, along with Dr. Thomas Tu, Molecular Biologist at the Westmead Institute for Medical Research in Australia. Together, they discuss expanding hepatitis B treatment guidelines by broadening eligibility criteria, improving access, reducing loss to follow-up, and the importance of including public health and patient perspectives in guideline development. 

Read more about their new paper here: https://pubmed.ncbi.nlm.nih.gov/40714036/

Support the show

Our website: www.hepb.org
Support B Heppy!
Social Media: Instagram - Twitter - Facebook